AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,019,866 | +564.0% | 335,777 | +265.8% | 0.00% | – |
| Q3 2022 | $756,000 | +28.6% | 91,802 | +2.5% | 0.00% | – |
| Q2 2022 | $588,000 | -11.6% | 89,600 | -24.6% | 0.00% | – |
| Q1 2022 | $665,000 | -38.8% | 118,800 | -48.7% | 0.00% | – |
| Q4 2021 | $1,087,000 | +21.3% | 231,627 | +59.7% | 0.00% | – |
| Q3 2021 | $896,000 | +18.1% | 145,035 | +25.9% | 0.00% | – |
| Q2 2021 | $759,000 | -59.5% | 115,200 | -55.0% | 0.00% | – |
| Q1 2021 | $1,872,000 | +138.2% | 255,769 | +87.9% | 0.00% | – |
| Q4 2020 | $786,000 | -11.2% | 136,122 | -8.7% | 0.00% | – |
| Q3 2020 | $885,000 | -64.8% | 149,126 | -69.5% | 0.00% | -100.0% |
| Q2 2020 | $2,516,000 | +1710.1% | 488,603 | +1169.7% | 0.00% | – |
| Q1 2020 | $139,000 | – | 38,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 835,000 | $6,112,000 | 0.90% |
| NEA Management Company, LLC | 3,952,958 | $28,936,000 | 0.65% |
| X-Square Capital, LLC | 101,248 | $741,000 | 0.34% |
| Monashee Investment Management LLC | 250,000 | $1,830,000 | 0.28% |
| Cormorant Asset Management, LP | 1,500,000 | $10,980,000 | 0.24% |
| CLOUGH CAPITAL PARTNERS L P | 300,000 | $2,196,000 | 0.10% |
| Maven Securities LTD | 225,000 | $1,604,000 | 0.07% |
| XTX Topco Ltd | 15,292 | $112,000 | 0.05% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $168,000 | 0.04% |
| PDT Partners, LLC | 46,666 | $342,000 | 0.02% |